Inhibition of human gingival carcinoma cell growth by prostaglandins
- 31 December 1987
- journal article
- research article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 19 (2) , 273-276
- https://doi.org/10.1016/0306-3623(88)90075-4
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Requirement of a reactive α,β-unsaturated carbonyl for inhibition of tumor growth and induction of differentiation by “A” series prostaglandinsBiochemical and Biophysical Research Communications, 1985
- Prostaglandin D2 inhibits the proliferation of human neuroblastoma cellsCancer Letters, 1983
- 9-Deoxy-Δ9-prostaglandin D2, a prostaglandin D2 derivative with potent antineoplastic and weak smooth muscle-contracting activitiesBiochemical and Biophysical Research Communications, 1982
- Prostaglandin D2, a potential antineoplastic agentBiochemical and Biophysical Research Communications, 1982
- Prostaglandin A1 and E1 inhibit the plating efficiency and proliferation of murine melanoma cells (Cloudman S-91) in soft agarBiochemical and Biophysical Research Communications, 1982
- Prostaglandins and cancer: A review of tumor initiation through tumor metastasisProstaglandins, 1981
- The effect of PGA1 on the immune response in B-16 melanoma-bearing miceProstaglandins, 1980
- A comparison of the vasodepressor effects of the cyclic endoperoxides PGG2 and PGH2 with those of PGD2 and PGE2 in hypertensive and normotensive ratsEuropean Journal of Pharmacology, 1976
- Prostaglandin A1 inhibition of chondrosarcoma growthBiochemical and Biophysical Research Communications, 1974
- Prostaglandins A1, A2 and 19‐hydroxy A1; their actions on smooth muscle and their inactivation on passage through the pulmonary and hepatic portal vascular bedsBritish Journal of Pharmacology, 1969